Skip to content
Annika Bansal – Lifestyle
Author:
Monopar Therapeutics Inc.
Monopar Announces Publication of Phase 2 Study Demonstrating ALXN1840 Significantly Improves Copper Balance in Patients with Wilson Disease
May 19, 2026
←
Previous Page
1
2